A detailed history of E Fund Management Co., Ltd. transactions in Boston Scientific Corp stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 53,574 shares of BSX stock, worth $4.88 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
53,574
Previous 4,410 1114.83%
Holding current value
$4.88 Million
Previous $339,000 1224.19%
% of portfolio
0.23%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $3.59 Million - $4.13 Million
49,164 Added 1114.83%
53,574 $4.49 Million
Q2 2024

Aug 12, 2024

SELL
$67.33 - $77.71 $27,807 - $32,094
-413 Reduced 8.56%
4,410 $339,000
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $12,441 - $14,821
216 Added 4.69%
4,823 $330,000
Q4 2023

Feb 06, 2024

BUY
$48.64 - $57.81 $33,221 - $39,484
683 Added 17.41%
4,607 $266,000
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $15,157 - $16,513
-302 Reduced 7.15%
3,924 $207,000
Q2 2023

Aug 11, 2023

SELL
$49.72 - $54.64 $25,705 - $28,248
-517 Reduced 10.9%
4,226 $229,000
Q1 2023

May 11, 2023

SELL
$45.09 - $50.03 $14,744 - $16,359
-327 Reduced 6.45%
4,743 $237,000
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $31,845 - $38,012
-805 Reduced 13.7%
5,070 $235,000
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $14,023 - $41,890
382 Added 6.95%
5,875 $228,000
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $4,722 - $6,311
134 Added 2.5%
5,493 $205,000
Q1 2022

May 12, 2022

SELL
$40.9 - $45.1 $31,329 - $34,546
-766 Reduced 12.51%
5,359 $237,000
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $5,367 - $6,326
141 Added 2.36%
6,125 $260,000
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $40,900 - $45,512
992 Added 19.87%
5,984 $260,000
Q1 2021

May 12, 2021

BUY
$35.27 - $39.67 $176,067 - $198,032
4,992 New
4,992 $192,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.